Invokana
Bayer data for kidney disease hope finerenone sets up filings
Phil Taylor
AstraZeneca, Bayer, chronic kidney disease, Farxiga, finerenone, Invokana, Johnson & Johnson, SGLT2 inhibitors, Type 2 diabetes
0 Comment
X
Bayer data for kidney disease hope finerenone sets up filings
https://pharmaphorum.com/news/bayer-data-for-kidney-disease-hope-finerenone-sets-up-filings/
Janssen taps wearable tech in Invokana heart failure trial
Phil Taylor
digital, heart failure, Invokana, Janssen, Johnson & Johnson, SGLT2 inhibitors, wearable
0 Comment
X
Janssen taps wearable tech in Invokana heart failure trial
https://pharmaphorum.com/news/janssen-taps-wearable-tech-in-invokana-heart-failure-trial/
X
FDA clears cardiovascular claim for J&J’s Invokana
https://pharmaphorum.com/news/fda-clears-cardiovascular-claim-for-jjs-invokana/